Abstract
Hyaluronic acid (HA) is a popular product frequently used for soft tissue augmentation. A new high-concentration HA–lidocaine product (Elevess, Anika Therapeutics, Inc., Bedford, MA) has gained recent popularity for its marketed safety and patient comfort on administration. We report a clinical case of a 21-year-old woman who suffered a severe adverse reaction after administration of this product to the nasolabial folds and lips. She developed facial cellulitis accompanied by a multitude of abscesses. After urgent incision and drainage, the abscess cultures grew Enterococcus faecalis. After a 7-day hospital course and home antibiotic regimen, the patient’s symptoms improved dramatically. It took 1 month for complete resolution of the patient’s signs and symptoms. Patients and practitioners should be aware of all of the possible effects and complications that may result from use of this and all other dermal fillers. They should be cognizant of proper injection technique and respond with appropriate urgency to signs of infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
